Over-expressing homologous antigen vaccine and a method of making the same
Boyle, Stephen M.
Corbeil, Lynette B.
Schurig, Gerhardt G.
MetadataShow full item record
This invention relates to an over-expressing homologous antigen vaccine, a method of producing the same, and use of the vaccine for prophylaxis or treatment of vertebrates at risk of or suffering from disease caused by a pathogenic micro-organism. The vaccine is an attenuated or avirulent pathogenic micro-organism that over-expresses at least one homologous antigen encoded by at least one gene derived from the pathogenic micro-organism, and may also express a heterologous antigen.
The Regents of the University of California
Virginia Tech Intellectual Properties, Inc.
- Virginia Tech Patents